ANTHROMOLECULE
Live / Applied — First extension granted (statement of use) (as of 14 Feb 2026)
What this means for you
Not registered yet, but its 04 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97871746
- Mark type
- Stylized text
- Filed
- 04 Apr 2023
- Published for opposition
- 24 Dec 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Nutritional supplements; medical foods, namely, infant, pediatric and adult formulas being dietetic beverages for nutrition purposes; pharmaceutical and therapeutic products, namely, pharmaceutical preparations for the treatment of immunological or metabolic diseases, infectious disease, nutritional deficiencies, oncological disease
Owner
- MONTAI THERAPEUTICS, INC., CAMBRIDGE, MA, US
- MONTAI THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Montai Health, Inc., Cambridge, MA, US
Prosecution history
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2026 — SOU EXTENSION 1 GRANTED
- 14 Aug 2025 — SOU EXTENSION 1 FILED
- 14 Feb 2026 — CORRECTED NOA E-MAILED
- 14 Feb 2026 — DIVISIONAL PROCESSING COMPLETE
- 14 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 13 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2024 — PUBLISHED FOR OPPOSITION
- 18 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER